Abbott Labs, Blackstone Among Mega Deals As Medtech M&A Topped $92B in 2025

In 2025, the medtech sector saw a noteworthy transaction value spike to $92.8 billion, largely fueled by three major acquisitions, but overall M&A activity remained muted with only 46 deals reported. Prominent transactions included Abbott Laboratories’ $23.5 billion acquisition of Exact Sciences, reflecting sustained interest in molecular diagnostics. Despite these high-profile deals, the M&A landscape faced challenges from regulatory uncertainties and economic pressures, leading to extended diligence and tighter execution standards. Looking ahead, the report suggests companies with strong digital infrastructures and measurable clinical outcomes may be better positioned to navigate these complexities in the evolving healthcare environment.

Opens on MobiHealthNews